Common Contracts
7 similar null contracts by Acorda Therapeutics Inc
September 1, 2020 Kerry ClemAcorda Therapeutics Inc • September 9th, 2021 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement (“Agreement”), setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Executive Vice President, Sales, Market Access and Operations. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2020 (the "Effective Date").
September 1, 2017Acorda Therapeutics Inc • March 9th, 2018 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Technology Officer and Site Head. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2017 (the "Effective Date"). We note that you previously entered into an employment agreement with Civitas Therapeutics, Inc. (“Civitas”), a wholly-owned subsidiary of the Company, and upon the Effective Date the existing Civitas employment agreement will terminate and be superseded in its entirety by this letter agreement.
September 1, 2017Acorda Therapeutics Inc • March 1st, 2018 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Technology Officer and Site Head. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2017 (the "Effective Date"). We note that you previously entered into an employment agreement with Civitas Therapeutics, Inc. (“Civitas”), a wholly-owned subsidiary of the Company, and upon the Effective Date the existing Civitas employment agreement will terminate and be superseded in its entirety by this letter agreement.
As of July 1, 2016Acorda Therapeutics Inc • November 7th, 2016 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement, setting out the terms of your employment with Acorda Therapeutics, Inc. (the "Company") as Chief Medical Officer. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of July 1, 2016 (the "Effective Date").
June 8, 2015Acorda Therapeutics Inc • August 7th, 2015 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Medical Officer. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of June 8, 2015 (the "Effective Date").
June 8, 2015 Lauren Sabella Fairfield, CT 06825 Dear Lauren:Acorda Therapeutics Inc • August 7th, 2015 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Commercial Officer. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of June 8, 2015 (the "Effective Date").
ContractAcorda Therapeutics Inc • March 3rd, 2014 • Biological products, (no disgnostic substances) • New York
